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Accumulated exposure to hormones and growth factors during early life may influence the future risk of breast 
cancer (BC). This study examines the influence of childhood-related, socio-demographic and anthropometric 
variables on BC risk, overall and by specific pathologic subtypes. 
 
Methods 
This is a case-control study where 1539 histologically-confirmed BC cases (23-85 years) and 1621 population 
controls, frequency matched by age, were recruited in 10 Spanish provinces. Perinatal and childhood-related 
characteristics were directly surveyed by trained staff. The association with BC risk, globally and according to 
menopausal status and pathologic subtypes, was evaluated using logistic and multinomial regression models, 
adjusting for tumor specific risk factors. 
 
Results 
Birth characteristics were not related with BC risk. However, women with high socioeconomic level at birth 
presented a decreased BC risk (OR=0.45; 95%CI=0.29-0.70), while those whose mothers were aged over 39 years 
at their birth showed an almost significant excess risk of hormone receptor positive tumors (HR+) (OR=1.35; 
95%CI=0.99-1.84). Women who were taller than their girl mates before puberty showed increased postmenopausal 
BC risk (OR=1.26; 95%CI=1.03-1.54) and increased HR+ BC risk (OR=1.26; 95%CI=1.04-1.52). Regarding 
prepubertal weight, while those women who were thinner than average showed higher postmenopausal BC risk 
(OR=1.46; 95%CI=1.20-1.78), associated with HR+ tumors (OR=1.34; 95%CI=1.12-1.61) and with triple negative 
tumors (OR=1.56; 95%CI=1.03-2.35), those who were heavier than average presented lower premenopausal BC 




These data reflect the importance of hormones and growth factors in the early stages of life, when the mammary 
gland is in development and therefore more vulnerable to proliferative stimuli. 
 
Keywords: breast cancer subtypes, childhood factors, perinatal factors, early life factors,  case-control study, Spain, hormone 
receptor, maternal age, childhood height, childhood weight. 
 
1. Introduction 
Breast cancer (BC) is the most frequent cause of cancer in Spanish women, with more than 25,200 new cases 
diagnosed per year [1]. During the last decades of the 20th century, it showed a steady increase in incidence, even 
among women younger than 45 years, though trends seem to level off  in 2001 [2] . It is also the tumor with the 
highest mortality rate in Spanish women, accounting for 15.6% of all female cancer-related deaths in 2013 [3]. 
 
The intrauterine environment may influence the subsequent risk of BC in female offspring.  Endogenous pregnancy 
hormones can act as growth factors increasing the stem cell population (and thereby the size of the organ and the 
number of susceptible stem cells later in life) or inducing cell proliferation. In so doing, these hormones increase 
the risk for genetic errors (oncogenic mutations or spontaneous somatic mutations), as well as the expansion of 
initiated clones. Additionally, estrogens and their metabolites can also act as genotoxic agents [4, 5]. Epidemiologic 
studies have shown moderate positive associations of BC risk with birthweight, birth length, maternal age and twin 
pregnancies; in contrast, pre-eclampsia or eclampsia seem to be inversely associated with the risk of this tumor [6-
9].  
 
Puberty is also a critical period for mammary gland development. Just before puberty, an exponential growth of the 
mammary gland, characterized by formation of terminal end buds, begins. These structures are considered the 
most vulnerable targets for carcinogens, and are still abundant during adolescence [10, 11]. There are studies that 
have described a positive relationship between BC risk and childhood height or height velocity as well as an 
inverse association with childhood obesity or body mass index (BMI) velocity [12-16].  
 
BC represents a heterogeneous disease, and its risk factors vary by molecular-based BC subtypes [17, 18]. This 
study sought to investigate whether perinatal and childhood sociodemographic and anthropometric factors 
influence the risk of BC in adulthood, using a large population-based case control study in Spain. In addition, we 
also assessed whether these associations differed by specific BC subtypes. 
 
 
2. Materials and Methods 
2.1 Study population 
Multicase Control Spain (MCC-Spain) is a case-control study with population controls and incident cases treated in 
the oncologic units of 23 hospitals located in 12 Spanish provinces (Barcelona, Madrid, Navarra, Gipuzkoa, León, 
 
Asturias, Murcia, Huelva, Cantabria, Valencia, Granada and Girona). It was carried out with the purpose to 
evaluate environmental and genetic factors associated with the risk of colorectal, breast, prostate, gastric tumors 
and chronic lymphocytic leukemia. Inclusion criteria required that participants had lived for at least 6 months in the 
study areas, were between 20-85 years old and were able to answer the epidemiological questionnaire. Given the 
hospitals and the resources available to us, the initial intention was to collect at least 1500 breast, 1500 colorectal 
cancer cases, 1000 prostate cancer cases, 500 gastric cancer cases and 500 chronic lymphocytic leukemias. 
Cases were identified as soon as possible after their diagnosis, through active search that included hospital 
admission registries and periodical visits to the collaborating hospital departments (i.e. gynecology, oncology, 
general surgery, radiotherapy and pathology departments, and breast cancer  multidisciplinary units). Between 
September 2008 and December 2013 we recruited a total of 1738 histologically-confirmed BC cases (ICD-10: C50, 
D05.1, D05.7) with complete interviews and informed consent in 10 of these provinces (all except Murcia and 
Granada).  
 
Population controls were randomly selected from the general practitioner lists of the hospital catchment area and  
were frequency matched to cases by age, sex and region, ensuring that in each region there was at least one 
control of the same sex and 5-year interval for each case. Participants were contacted by telephone, and those 
who agreed to participate signed an informed consent. We recruited a total of 1910 female controls. The study was 
approved by the Ethics Committee of all hospitals and participant primary care centers. Fig.1  show a flow chart 
displaying the selection process of breast cancer cases and controls. More details regarding the design of the 
study are provided elsewhere [19]. 
 






2.2 Data collection 
Trained interviewers administered a structured computerized epidemiological questionnaire in a face-to-face 
interview. This questionnaire recorded sociodemographic and anthropometric data, family and personal history, 
gynecological, obstetric, medical, residential and occupational history, smoking and physical activity. Finally cases 
and controls completed a validated food frequency questionnaire. With respect to perinatal factors, the 
questionnaire collected information on socioeconomic level at birth (income of their parents when the women were 
born), maternal and paternal age at birth, birthweight, birth order and premature birth. With respect to childhood 
factors, the questionnaire collected information about how women were before having their first menstruation in 
comparison with their girl mates (heavier than average; average; thinner than average or taller than average; 
average; shorter than average) and age at menarche.  
 






Not met the inclusion criteria:
70 not incident cases
35 not confirmed by pathological report
28 resident outside the study area
1 less than 6 months in study area
34 younger than 20 or older than 85 years
14 unable to answer the questionnaire
n=793
Non participants:
780 refused to participate












79 from areas not recruiting BC cases
49 with personal history of BC
CASES CONTROLS
n=199
Missing data in key covariates
n=1539
Cases included in the
present work
n=289
Missing data in key covariates
n=1621
BC controls included
in the present work
 
Trained personnel reviewed all pathology records and registered information regarding estrogen receptor (ER), 
progesterone receptor (PR) and the human epidermal growth factor receptor (HER2) in BC cases. So, BC cases 
were sub classified by the following subtypes: hormone receptor positive tumors (HR+) (ER+ or PR+ with HER2-), 
HER2+ tumors (independent of ER or PR) and triple negative (TN) tumors (ER-, PR- and HER2-).  
 
2.4 Statistical analyses 
Descriptive analyses of participants’ characteristics were performed for cases and controls. Categorical variables 
were described using absolute figures and percentages, and continuous variables using means and standard 
deviations. Significant differences between cases and controls were tested using Pearson chi-square for 
categorical variables and Student's t-test for continuous variables assuming equal variances.  
 
The association of perinatal and childhood variables with BC risk was evaluated using logistic mixed regression 
models, including the province as a random effect term, as implemented in Stata´s gllamm command [20]. Models 
were adjusted for age, educational level, BMI one year before the interview, age at first birth, age at menarche, 
previous biopsies, family history of BC and menopausal status. We also conducted stratified analyses by 
menopausal status. Heterogeneity of effects among pre and postmenopausal women were assessed, including an 
interaction term between menopausal status and the corresponding variable of interest. 
 
Finally, multinomial logistic regression models were used to evaluate the association of perinatal and childhood 
factors with each of the above-mentioned BC subtypes. These models were adjusted by the same set of variables 
described above, including the province as a random effect term.  Heterogeneity of effects was tested using a Wald 
test comparing the coefficients obtained for the different cancer subtypes. All analyses were performed in 
STATA/MP 13.1 software. 
 
3. Results 
Response rates were 53.8% for healthy female controls and 68.7% for BC cases. Results presented in this 
manuscript are based on participants with no missing values in any of the selected confounders: 1539 BC cases 
(89%) and 1621 controls (85%). Table 1 shows the main characteristics of this population. In general, cases were 
slightly younger and had fewer children than controls. A sensitivity analysis testing the distribution of these 
variables in cases and controls excluded due to lack of information on any of the selected confounders showed 




Table 1: Socio-demographic characteristics of breast cancer cases and controls 
    BC cases  Controls    
    (N=1539) (N=1621) p-val 
Age, mean(SD) 56.0(12.1) 58.2(12.7) <0.001 
Educational level, N(%) 
   
 
less than primary school 215(14%) 235(14%) 
 
 
primary school completed 504(33%) 489(30%) 
 
 
secondary school 512(33%) 521(32%) 
 
 
university graduate 308(20%) 376(23%) 0.120 
BMI, N(%) 



















 287(19%) 288(18%) 0.130 
Menopausal status, N(%) 
   
 
premenopausal 540(35%) 485(30%) 
 
 
peri-postmenopausal 999(65%) 1136(70%) 0.002 
Number of children, N(%) 
   
 
none 311(20%) 308(19%) 
 
 
1-2 904(59%) 907(56%) 
 
 
3-4 284(18%) 341(21%) 
 
 
>4 40(3%) 65(4%) 0.029 
Age at first birth, mean(SD) 26.7(4.9) 26.7(4.8) 0.939 
Age at menarche, mean(SD) 12.8(1.6) 12.8(1.6) 0.139 
Previous biopsies, N(%) 
   
 
none 1420(92%) 1585(98%) 
 
 
yes 119(8%) 36(2%) <0.001 
Family history of breast cancer, N(%) 
  
 
none 1152(75%) 1386(86%) 
 
 
second degree only 161(10%) 91(6%) 
 
 
1 first  degree 197(13%) 134(8%) 
   >1 first degree 29(2%) 10(1%) <0.001 
 
Table 2 shows the association between BC and perinatal and childhood factors, both globally and stratified by 
menopausal status. Although the number of cases was low, pre and postmenopausal women with high 
socioeconomic level at birth showed a decreased risk of BC (OR=0.45; 95%CI=0.29-0.70). Those women whose 
mother was aged over 39 years at their birth displayed greater BC risk (OR:1.30; 95%CI=0.98-1.73), although this 
result failed to attain statistical significance. Participants who reported being thinner than average during their 
prepubertal period showed an increased risk of BC (OR=1.34; 95%CI=1.14-1.57), and this association was 
stronger among postmenopausal women (OR=1.46; 95%CI=1.20-1.78). By contrast, those who reported being 
heavier than average during childhood showed decreased premenopausal BC risk (OR=0.64; 95%CI=0.46-0.90). 




Table 3 summarizes these results by BC tumor subtypes. In general, 66% of BC cases were HR+, 17% were 
HER2+ and 8% were TN tumors (similar to percentages described by another Spanish population-based study 
[21]. We could not classify 137 (9%) BC cases. The inverse association with socioeconomic level at birth was 
mainly confirmed for HR+ tumors, although, again, the number of cases in the high socioeconomic level was very 
low. The increased risk associated with advanced maternal age was almost significant for HR+ tumors (OR >39 
years=1.35; 95%CI=0.99-1.84). Women who were taller than average in their prepubertal period also showed an 
increased risk of HR+ tumors (OR=1.26; 95%CI=1.04-1.52). Finally, with regard to prepubertal weight, those 
women who were thinner than average showed increased risk of HR+ (OR=1.34; 95%CI=1.12-1.61) and TN 
tumors (OR=1.56; 95%CI=1.03-2.35) while those who were heavier presented lower HER2+ BC risk (OR=0.61; 
95%CI=0.40-0.93). 
 
We didn’t find any significant association with other perinatal or childhood variables, such as paternal age at birth, 




Table 2: Association between birth and childhood characteristics and breast cancer risk, both overall and broken down by menopausal status 
        All women (N=3160) Pre-menopausal women (N=1025) Post-menopausal women  (N=2135)   
    Cases controls OR
a
 95% CI P Cases controls OR
a
 95% CI P Cases controls OR
a
 95% CI P P-int.
b
 
Socio-economic level at birth 
      
              
       
  
 
low 489 533 0.94 0.80 - 1.11 0.477 131 117 0.97 0.72 - 1.30 0.818 358 416 0.93 0.77 - 1.13 0.481   
 
middle 1017 1007 1.00 
    
398 343 1.00         619 664 1.00 
    
  
 
high 30 78 0.45 0.29 - 0.70 <0.001 10 23 0.42 0.19 - 0.91 0.027 20 55 0.46 0.27 - 0.80 0.005 0.956 
Maternal age at birth 
       
              
       
  
 
<30 years 708 793 1.00 
    
258 252 1.00         450 541 1.00 
    
  
 
30–34 years 388 369 1.13 0.94 - 1.35 0.184 157 116 1.27 0.93 - 1.72 0.129 231 253 1.06 0.85 - 1.33 0.603   
 
35–39 years 194 208 1.01 0.80 - 1.26 0.949 71 65 1.07 0.73 - 1.58 0.723 123 143 0.97 0.74 - 1.29 0.858   
 




1.04 0.98 - 1.11 0.174     1.06 0.95 - 1.17 0.310 
  
1.04 0.96 - 1.11 0.339 0.819 
Paternal age at birth
c
 
       
              
       
  
 
<30 years 451 516 1.00 
    
165 170 1.00         286 346 1.00 
    
  
 
30–34 years 410 408 1.07 0.87 - 1.32 0.509 152 124 1.19 0.85 - 1.67 0.321 258 284 1.02 0.79 - 1.31 0.871   
 
35–39 years 268 240 1.18 0.90 - 1.55 0.238 116 79 1.43 0.96 - 2.13 0.078 152 161 1.06 0.76 - 1.46 0.736   
 




1.00 0.91 - 1.09 0.936     1.02 0.90 - 1.14 0.788 
  
0.99 0.90 - 1.09 0.793 0.534 
Firstborn baby 
       
              
       
  
 
no 1111 1153 1.00 
    
392 348 1.00         719 805 1.00 
    
  
 
yes 413 449 1.00 0.85 - 1.17 0.971 145 133 1.02 0.77 - 1.35 0.906 268 316 1.00 0.81 - 1.20 0.899 0.865 
Premature baby 
       
              
       
  
 
no 1423 1522 1.00 
    
502 456 1.00         921 1066 1.00 
    
  
 
yes 72 65 1.14 0.80 - 1.63 0.456 24 26 0.75 0.42 - 1.35 0.339 48 39 1.45 0.93 - 2.26 0.098 0.078 
Birth weight 
    
  
  
              
       
  
 
<2.5 Kg 74 61 1.27 0.89 - 1.83 0.189 28 22 1.06 0.59 - 1.92 0.848 46 39 1.42 0.90 - 2.23 0.132   
 
2.5-3.9 Kg 987 1074 1.00 
    
381 346 1.00         606 728 1.00 
    
  
 
>3.9 Kg 157 164 1.05 0.82 - 1.33 0.721 56 53 0.95 0.63 - 1.43 0.793 101 111 1.10 0.82 - 1.49 0.522   
 




0.95 0.78 - 1.16 0.616     0.94 0.68 - 1.31 0.726 
  
0.96 0.75 - 1.22 0.715 0.806 
Prepubertal height 
       
              
       
  
 
shorter than average 237 258 1.00 0.82 - 1.23 0.971 83 87 0.83 0.58 - 1.18 0.295 154 171 1.11 0.86 - 1.43 0.436   
 
average 834 912 1.00 
    
296 252 1.00         538 660 1.00 
    
  
 
taller than average 460 442 1.15 0.98 - 1.36 0.094 160 145 0.97 0.72 - 1.29 0.811 300 297 1.26 1.03 - 1.54 0.027 0.218 
Prepubertal weight 
       
              
       
  
 
thinner than average 693 614 1.34 1.14 - 1.57 <0.001 215 169 1.11 0.83 - 1.48 0.475 478 445 1.46 1.20 - 1.78 <0.001   
 
average 583 670 1.00 
    
222 188 1.00         361 482 1.00 
    
  
 
heavier than average 255 328 0.84 0.69 - 1.04 0.106 101 124 0.64 0.46 - 0.90 0.010 154 204 0.99 0.76 - 1.28 0.922 0.095 
Age at menarche 
       
              
       
  
 
<13 years 678 688 1.00 
    
251 215 1.00         427 473 1.00 
    
  
 
13 years 392 393 1.07 0.87 - 1.32 0.535 148 132 1.02 0.75 - 1.38 0.919 244 261 1.07 0.86 - 1.35 0.539   
 
>13 years 469 540 0.97 0.80 - 1.19 0.785 141 138 0.94 0.69 - 1.27 0.685 328 402 0.97 0.79 - 1.19 0.762   
  trend per year     1.00 0.90 - 1.11 0.967     1.00 0.92 - 1.10 0.948     0.98 0.93 - 1.04 0.489 0.959 
a 
OR and 95% CI adjusted for age, study level, BMI 1-year before the interview, age at first birth, previous biopsies, family history of breast cancer, age at menarche and menopausal status 
b 
P-int.:  P value of the interaction term between menopausal status and the corresponding variable  
            c Additionally adjusted by maternal age at birth 
                   
 
In italics: ORs, 95% CI and P values obtained with the corresponding variable as a continuous term 
             
Table 3: Association between birth and childhood characteristics and breast cancer risk by tumor subtype 
         Controls HR+ (N=1016) HER2+ (N=265) TN (N=121)   
    (N=1621) Cases OR
a
 95% CI P Cases OR
a
 95% CI P Cases OR
a
 95% CI P P-het.
b
 
Socio-economic level at birth             
      
            
 
 
low 533 339 1.02 0.85 - 1.23 0.818 76 0.81 0.59 - 1.10 0.173 39 0.94 0.62 - 1.42 0.758 
 
 
middle 1007 653 1.00         181 1.00 
    
81 1.00         
 
 
high 78 21 0.49 0.30 - 0.82 0.007 8 0.69 0.32 - 1.49 0.347 1 -         0.244 
Maternal age at birth 
 
            
      
            
 
 
<30 years 793 457 1.00         125 1.00 
    
63 1.00         
 
 
30–34 years 369 262 1.17 0.95 - 1.43 0.130 63 1.06 0.76 - 1.48 0.725 30 0.98 0.62 - 1.54 0.918 
 
 
35–39 years 208 130 1.03 0.80 - 1.33 0.796 36 1.08 0.72 - 1.62 0.720 11 0.65 0.33 - 1.26 0.200 
 
 





  1.05 0.98 - 1.13 0.132 
 
1.05 0.94 - 1.17 0.376   0.90 0.77 - 1.06 0.203 0.169 




            
      
            
 
 
<30 years 516 291 1.00         75 1.00 
    
45 1.00         
 
 
30–34 years 408 270 1.06 0.84 - 1.34 0.626 72 1.23 0.84 - 1.82 0.291 30 0.98 0.57 - 1.68 0.940 
 
 
35–39 years 240 184 1.18 0.87 - 1.61 0.283 47 1.46 0.88 - 2.41 0.139 17 1.06 0.51 - 2.19 0.873 
 
 





  0.97 0.88 - 1.07 0.590 
 
1.11 0.95 - 1.30 0.184   0.96 0.76 - 1.22 0.759 0.258 
Firstborn baby 
 
            
      
            
 
 
no 1153 734 1.00         202 1.00 
    
88 1.00         
 
 
yes 449 270 1.00 0.83 - 1.20 0.978 62 0.81 0.59 - 1.11 0.184 32 0.98 0.64 - 1.50 0.922 0.427 
Premature baby 
 
            
      
            
 
 
no 1522 939 1.00         244 1.00 
    
110 1.00         
 
 
yes 65 48 1.16 0.78 - 1.72 0.457 14 1.26 0.69 - 2.31 0.445 6 1.18 0.50 - 2.81 0.702 0.964 
Birth weight 
 
            
      
            
 
 
<2.5 Kg 61 43 1.11 0.73 - 1.67 0.639 17 1.62 0.91 - 2.86 0.098 6 1.26 0.52 - 3.02 0.608 
 
 
2.5-3.9 Kg 1074 648 1.00         171 1.00 
    
79 1.00         
 
 
>3.9 Kg 164 110 1.13 0.86 - 1.48 0.381 26 0.98 0.62 - 1.54 0.934 14 1.15 0.63 - 2.09 0.655 
 
 





  1.05 0.85 - 1.31 0.631 
 
0.82 0.58 - 1.17 0.281   1.03 0.63 - 1.67 0.904 0.410 
Prepubertal height 
 
            
      
            
 
 
shorter than average 258 153 1.00 0.79 - 1.27 0.993 42 0.97 0.67 - 1.41 0.863 23 1.26 0.76 - 2.07 0.371 
 
 
average 912 538 1.00         153 1.00 
    
66 1.00         
 
 
taller than average 442 319 1.26 1.04 - 1.52 0.016 68 0.93 0.68 - 1.27 0.642 32 1.06 0.68 - 1.65 0.810 0.161 
Prepubertal weight 
 
            
      
            
 
 
thinner than average 614 452 1.34 1.12 - 1.61 0.002 122 1.28 0.96 - 1.71 0.091 60 1.56 1.03 - 2.35 0.035 
 
 
average 670 377 1.00         107 1.00 
    
43 1.00         
 
 
heavier than average 328 182 0.94 0.75 - 1.18 0.598 34 0.61 0.40 - 0.93 0.020 18 0.81 0.46 - 1.44 0.478 0.260 
Age at menarche 
 
            
      
            
 
 
<13 years 688 449 1.00         117 1.00 
    
46 1.00         
 
 
13 years 393 260 1.06 0.86 - 1.29 0.605 62 1.00 0.71 - 1.40 0.992 37 1.45 0.92 - 2.29 0.107 
 
 
>13 years 540 307 0.94 0.77 - 1.14 0.500 86 1.08 0.79 - 1.48 0.615 38 1.11 0.71 - 1.75 0.648 
   trend per year     0.98 0.93 - 1.03 0.450   1.01 0.93 - 1.10 0.782   1.06 0.94 - 1.19 0.330 0.383 
 
a
 OR and 95% CI adjusted for age, study level, BMI 1-year before the interview, age at first birth, previous biopsies, family history of breast cancer, age at menarche and menopausal status 
b
 P-het.: P value of heterogeneity of effect between pathologic subtypes 
             c Additionally adjusted by maternal age at birth 
           
  
      In italics: ORs, 95 % CI and P values obtained with the corresponding variable as a continuous term 
           
 
4. Discussion 
This paper examines the association between recalled perinatal and childhood factors and BC in the adult stage, 
and evaluates whether these effects differ by menopausal status and tumor subtype. As main results we can 
highlight the increased risk of HR+ tumors associated with advanced maternal age at birth and the inverse 
association with prepubertal weight among all tumor subtypes. 
 
One of the main strengths of this study is the use of histologically confirmed incident cases, as well as its 
substantial sample size, since it is the largest epidemiological study to date that analyses the association between 
BC risk and perinatal and childhood factors in the Spanish population. This is a multicenter study carried out in 10 
Spanish provinces located throughout the Spanish geography covering rural and urban areas and accounting for 
42% of the Spanish women according to the 2011 census [22]. Furthermore, it has been possible to evaluate 
potential interactions by menopausal status and explore possible differences by tumor subtypes. On the other 
hand, the statistical models used in this study included a random province-specific intercept term, which accounted 
for unexplained heterogeneity  across different regions. 
 
Several limitations should also be addressed. First, the explanatory variables of interest are self-reported and so 
they are subject to possible recall bias. However, if recall bias exists, it would probably be non-differential, thus 
implying an underestimation of the effects studied. To minimize recall error, the questionnaire included comparative 
measures, which are easier to recall than absolute measures. Furthermore, to recall prepubertal height and weight 
we also used visual body silhouettes, which have been validated as a reliable self-reported measure of adolescent 
body size [23], and we have found a high correlation between these two questions (Spearman’s coefficient of 
0.596; p-value<0.0001). On the other hand, these same questions were used in a previous published study [24] 
where we analyzed the influence of certain childhood-related variables on mammographic density in adult women, 
and we also detected an inverse association with prepubertal weight and a positive association with prepubertal 
height and with advanced maternal age at birth. Regarding a potential selection bias, we intended to recruit all 
cases with a first diagnosis of BC in the selected health areas, ensuring that very few incident cases were missed 
in the study. We could not use population cancer registries since in most of these regions there was not any such 
registry. Third, even though most established risk factors were taken into account in the present study, other 
unmeasured confounders may influence these associations. For example, alcohol consumption and diabetes were 
not considered here and according to the Spanish National Health Survey [25] , they are not equally distributed  in 
the areas of the study. However, these and other unmeasured characteristics with a geographical distribution have 
 
been at least partly accounted for through the random province term. Finally, we were limited by the small size 
when evaluating certain subgroup associations. This limitation hampered the analysis by BC subtypes, given the 
low frequency of TN tumors in our context.  
 
Our results show an almost significant increased risk of HR+ BC among women born to older mothers (>39 years). 
Several previous systematic reviews have described a positive association with maternal age at birth, although 
there is heterogeneity among studies [8, 9, 14, 26]. Similarly to the prospective cohort study published by Xue et al 
[27], we have detected a stronger association among postmenopausal women and among women with HR+ 
tumors. Mother’s age at birth has also been associated with higher mammorgraphic density [24], the most reliable 
phenotype risk marker for BC. These results would support the hypothesis that increased concentrations of 
endogenous hormones during pregnancy can alter BC risk in daughters [28]. However, the association between 
maternal age at birth and serum estrogen levels is not consistent; while some studies have reported no association 
[29, 30], others have found higher serum estrogen concentrations [31], higher bioavailability for estradiol [32] or 
higher levels of estrogen metabolites [33] among younger mothers. Finally, Panagiotopoulou et al. detected higher 
estradiol concentrations among mothers belonging to an intermediate age group [34]. 
 
Other hormones that seem to play a role in the intrauterine origin of BC are sex hormone-binding globulin (SHBG), 
insulin-like growth factor I (IGF-1), insulin-like growth factor II (IGF-2) [35] and androgens [36]. However, there are 
few studies linking these hormones with age at pregnancy. Chen et al  [37] detected higher serum IGF-1 and IGF-2 
levels in younger mothers during their first trimester, whereas Troisi et al [31] found higher androgen 
concentrations in these women. So, with the available data there is uncertainty about to what extent maternal age 
at pregnancy is a marker of hormonal exposure in utero. An alternative, non-intrauterine hypothesis is based on 
maternal mitochondrial oocyte inheritance [38]. Van Noord proposed that maternal age at birth reflects the quality 
of the mitochondria, with which an individual begins his or her life. From the meiosis-I time onwards, the mtDNA 
would start to accumulate mutations even in the resting nondividing oocyte, since circular mtDNA lacks protection 
by histones or the DNA repair system [38].  
 
Most studies analyzing the association between childhood fatness and BC have found an inverse relationship that 
seems to be stronger among premenopausal women [7, 39-43], although it has also been observed in the 
postmenopausal group [7, 40, 41, 44-46]. There are several hypotheses that have been postulated to explain this 
association. Childhood obesity has been associated with menstrual irregularities, anovulation and higher basal 
levels of insulin [47, 48]. Insulin acts on various organs to increase sex steroid bioavailability, and this 
 
overexposure to estrogens in obese prepubertal children could trigger early pubertal development [49-51], increase 
the expression of tumor suppressor genes (such as BRCA1) and induce early differentiation of mammary epithelial 
cells, reducing the probability of malignant transformations [15, 52]. However, no differences were detected in 
steroid hormone levels by BMI or childhood body shape in some studies [53, 54]. Conversely, an inverse 
association has been detected between childhood body fatness and adult IGF-1 levels [55, 56], protein which has 
been associate with an increased risk of BC among premenopausal women [57, 58]. Finally, reduced progesterone 
levels have been proposed as a possible explanation for the inverse association between BMI and BC before 
menopause [59], mainly because this reduction exerts a negative feedback on the hypothalamic pituitary release of 
gonadotropins. 
 
Although the inverse association between childhood body size and subsequent risk of BC is quite consistent, 
results by pathologic subtype are not homogenous. Faguerazzi et al only detected an inverse association with ER+ 
PR+ tumors [60], while Bardia et al described a stronger association with ER+/PR- tumors [44]. On the contrary, Li 
and Baer found a stronger effect for ER– subtypes [40, 45], and for HER2+ tumors  [40]. Finally, Sangaramorthy et 
al showed no differences by estrogen receptor status [42]. Our results, in consonance with those of Baer and Li 
[40, 45], show an inverse association more pronounced among HER2+ and TN tumors, supporting an alternative 
pathway not mediated by sex hormones.  
 
Previous studies have reported a positive association between BC and childhood height or height velocity [12, 13, 
61-63]. One possible pathway links height to the number of cells in the body. Larger bodies contain more cells 
susceptible to undergo malignant transformation [61].  Another explanation is the positive relationship between 
height and IGF1 levels [61, 64, 65]. In our analyses, the association with prepubertal height was mainly observed 
among HR+ tumors. This result is in consonance with the second hypothesis, given that the positive association of 
IGF1 with BC risk seems to be confined to estrogen receptor positive malignancies [66].  
 
Regarding socioeconomic level at birth, while some studies have found no association between BC and paternal 
occupational level [67] or maternal socioeconomic status [68], others have detected a positive relation with either 
paternal [69] or maternal education [70]. In the latter study, the effect was mediated by women’s adult 
socioeconomic status and reproductive behaviors, factors that have been taken into account in our analysis. In our 
case, results are based on a subjective rating made by our participants comparing their families with others around 
them. Here, the small group of women who reported being born in a high social class had lower risk of BC.  Lower 
socioeconomic status at birth could be a proxy of early-life conditions that could not be controlled for. For example, 
 
lower parental socioeconomic status is associated with a “western” dietary pattern [71], which has also been linked 
to BC risk [72]. On the other hand, women with lower parental education presented higher circulating levels of the 
inflammation marker C-reactive protein [73] and, therefore higher risk of BC [74]. 
 
Previous studies have reported an increased BC risk with heavier birth weight [8, 75]. However we  have not 
detected an association with this variable, although it should be noted that 21% of cases and 20% of controls were 
unable to answer. On the other hand, earlier age at menarche is consistently linked with an increased risk of 
premenopausal and postmenopausal BC [76]. However, we found no association, even though Spain is one of the 
European countries where age at menarche has decreased at a higher rate and since the 50s is one of the 
countries with a lower mean age [77].  
 
In brief, our results suggest an increased HR+ BC risk associated with advanced maternal age at birth. 
Furthemore, those women who were taller or thinner than their mates in their prepubertal stage showed higher 
postmenopausal BC risk, mainly associated with HR+ tumors, while those who were heavier presented lower 
premenopausal BC risk associated with HER2+ tumors. Some of these perinatal and childhood factors are not 
easily modifiable. The economic and social changes in recent decades have led to a significant change in the 
lifestyle of women, such as a considerable delay in the age at first birth. In fact, Spain is the European country with 
the highest mean age of women at childbirth [78], reaching 32.3 years in 2014 [79]. On the other hand, the inverse 
association between BC and childhood weight detected in our study should be interpreted  with caution in terms of 
prevention, especially when it is known that obesity is a stablished risk factor for postmenopausal BC [80] and that 
there is a strong positive association between high childhood BMI and adult obesity [81].  In this sense, Spain is 
one of the countries with higher risk of adult obesity-related morbidity, since it is the second country in Europe with 
the highest prevalence of childhood overweight and obesity [82], with 15.5% of obese girls aged 7-8 years in 2013 
[83]. Moreover, according to one study carried out in  screening attendants, Spanish women gained an average of 
400 g per year since the age of 18 years [84]. Our results corroborate that early life exposures affect  a woman’s 
long-term risk of BC, and hence, prevention efforts should begin earlier in life, targeting potentially modifiable risk 
factors. 
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